(PRWEB) February 27, 2014
The “High Content Screening Market by Instruments (Cell Imaging and Analysis System) by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018” analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and the Rest of the World (RoW).
Browse more than 50 market data tables with 10 figures spread through 151 pages and in-depth TOC on "High Content Screening Market"
Early buyers will receive 10% customization on this report.
The global high content screening market was valued at an estimated $362.2 million in 2013 and is expected to reach $615.8 million by 2018, growing at a CAGR of 11.2% from 2013 to 2018.
Inquiry Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=4271039.
Enhanced accuracy of cell imaging and analysis systems helps in reducing the drug discovery time period and costs, which is a major factor driving the growth of this market. Furthermore, the increasing use of HCS in toxicity studies in the early phase of drug discovery is another factor that propels the growth of this market. Government support for the growth of innovative technologies and rising demand for outsourcing of drug discovery services, especially in the Asian region, are also major reasons for the high growth of this market. Based on HCS products, the instruments market commanded the largest share of 43% in 2013. However, the HCS software market is poised to grow at the highest CAGR from 2013 to 2018.
Based on geography, the global high content screening market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America accounted for the largest share of the market in 2013. This large share of the North American region can be attributed to the various collaborations among prominent players for developing and marketing new products in the market.
The major players in the high content screening market include Thermo Fisher Scientific (U.S.), Molecular Devices (acquired by Danaher Corporation) (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Cell Signaling Technology (U.S.), Genedata AG (Switzerland), Merck KGaA (Germany), Thorlabs, Inc. (U.S.), and Yokogawa Electric Corporation (Japan), among others.
Browse Related Reports:
Nerve Repair & Regeneration Market by Xenografts (Conduits, Protectors), Neuromodulation [Internal (Spinal Cord, Deep Brain)], External (Transcranial Magnetic)], Surgery [Direct Nerve Repair, Grafting, Stem Cell] - Global Trend & Forecast to 2018
Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 – 2018)
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology.
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets.